Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Natarajan Venkatesan"'
Autor:
Devarasu, Pradeepraj, Natarajan, Venkatesan, Sendhamaraikannan, Thamizh, Velmurugan, Aravinth, Yokesh A., Nivedha B., Riswana S.
Publikováno v:
Journal of Advanced Zoology; 2024, Vol. 45 Issue 1, p977-984, 8p
Autor:
Gottfried E. Konecny, Dennis J. Slamon, Gerrit Los, Fritz Jänicke, Nitin Udar, Sugandha Dandekar, Hong-Mei Rong, Natarajan Venkatesan, Victor E. Velculescu, Siân Jones, Boris Winterhoff, Alexandra Meuter, Charles Ginther, Lee Anderson, Judy Dering, Meenal Chalukya, Kanthinh Manivong, Jing Wei Qi, Teodora Kolarova, Christine zu Eulenburg, Maike Ihnen
PDF file - 603K, Supplemental Figure S1: Gene maps of the BRCA1 (A) and BRCA2 (B) CpG islands examined with bisulfite pyrosequencing. Supplemental Figure S2: Anchorage independent growth inhibition at 1μM rucaparib in soft agar. Of the 39 tested ova
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3df54f80fb3880b007f62b7f6bbc31c4
https://doi.org/10.1158/1535-7163.22500252
https://doi.org/10.1158/1535-7163.22500252
Autor:
Gottfried E. Konecny, Dennis J. Slamon, Gerrit Los, Fritz Jänicke, Nitin Udar, Sugandha Dandekar, Hong-Mei Rong, Natarajan Venkatesan, Victor E. Velculescu, Siân Jones, Boris Winterhoff, Alexandra Meuter, Charles Ginther, Lee Anderson, Judy Dering, Meenal Chalukya, Kanthinh Manivong, Jing Wei Qi, Teodora Kolarova, Christine zu Eulenburg, Maike Ihnen
Here, we investigate the potential role of the PARP inhibitor rucaparib (CO-338, formerly known as AG014699 and PF-01367338) for the treatment of sporadic ovarian cancer. We studied the growth inhibitory effects of rucaparib in a panel of 39 ovarian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbeee4da3ffc16ade9b2433aa2b60aae
https://doi.org/10.1158/1535-7163.c.6536409.v1
https://doi.org/10.1158/1535-7163.c.6536409.v1
Autor:
Natarajan, Venkatesan1 venkatcology@gmail.com, B. A., Vishwanath2
Publikováno v:
Free Radicals & Antioxidants. Jul-Dec2021, Vol. 11 Issue 2, p38-41. 4p.
Autor:
Theodore C. Goldstein, Parameet Kumar, Santanu Raychaudhuri, Natarajan Venkatesan, Marcus Gallagher-Jones, Marco Morselli, Daniel Sanghoon Shin, Saroj K. Basak, Roopa Biswas, Matteo Pellegrini, Jing Lu, Trent Su, Eri S. Srivatsan, Sharon P. Wilczynski, Mysore S. Veena, Rita Chakrabarti, Haiquing Fu, Matthew Rettig, Mirit I. Aladjem
Publikováno v:
The Journal of biological chemistry, vol 295, iss 50
J Biol Chem
J Biol Chem
We have observed overexpression of PACS-1, a cytosolic sorting protein in primary cervical tumors. Absence of exonic mutations and overexpression at the RNA level suggested a transcriptional and/or posttranscriptional regulation. University of Califo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dd9515db6c5b92672b9eee20278a4f9
https://escholarship.org/uc/item/1h59m8rz
https://escholarship.org/uc/item/1h59m8rz
Autor:
JN O'Donnell, Gwendolyn M Pais, Marc H. Scheetz, Natarajan Venkatesan, RL Chapman, Brooke Griffin, H Nguyen, Nathaniel J. Rhodes, Joshi, Jack Chang
Publikováno v:
Clinical and Translational Science
A translational need exists to understand and predict vancomycin‐induced kidney toxicity. We describe: (i) a vancomycin high‐performance liquid chromatography (HPLC) method for rat plasma and kidney tissue homogenate; (ii) a rat pharmacokinetic (
Autor:
Anil Gulati, Thomas P. Lodise, J. Nicholas O'Donnell, Peter C. Lamar, Walter C. Prozialeck, Nathaniel J. Rhodes, Cameron Cluff, Gwendolyn M Pais, Natarajan Venkatesan, Marc H. Scheetz, Michael Neely
Publikováno v:
Antimicrobial Agents and Chemotherapy. 60:5742-5751
Vancomycin has been associated with acute kidney injury (AKI). However, the pharmacokinetic/toxicodynamic relationship for AKI is not well defined. Allometrically scaled vancomycin exposures were used to assess the relationship between vancomycin exp
Autor:
Mysore S. Veena, Daniel Sanghoon Shin, Chan Jeong, Jenna R. Chatoff, Natarajan Venkatesan, Saroj K. Basak, David Gray, Sharon P. Wilczynski, Steven J. Gray, Donald B. Kohn, Marilene B. Wang, Eri S. Srivatsan
Publikováno v:
Cancer Research. 80:5986-5986
Gigaxonin, the protein product of the Giant axonal neuropathy (GAN) gene, is a E3 ubiquitin ligase involved in neural cell and fibroblast intermediate filament processing. We have previously shown that Gigaxonin interacts with p16 in cisplatin-mediat
Publikováno v:
AAPS PharmSciTech. 20(1)
Lipids have been extensively used in formulations to enhance dissolution and bioavailability of poorly water-soluble as well as water-soluble drug molecules. The digestion of lipid-based formulations, in the presence of bile salts, phospholipids, and
Autor:
Alborz Zinabadi, Arthur W. Wu, Victor M. Duarte, Marilene B. Wang, Saroj K. Basak, Clifton L. Dalgard, Meera Srivastava, Eri S. Srivatsan, Natarajan Venkatesan, James J. Kang, Fazlul H. Sarkar
Publikováno v:
Oncotarget
Basak, SK; Zinabadi, A; Wu, AW; Venkatesan, N; Duarte, VM; Kang, JJ; et al.(2015). Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells. Oncotarget, 6(21), 18504-18517. doi: 10.18632/oncotarget.4181. UCLA: Retrieved from: http://www.escholarship.org/uc/item/7xs768kb
Oncotarget, vol 6, iss 21
Basak, SK; Zinabadi, A; Wu, AW; Venkatesan, N; Duarte, VM; Kang, JJ; et al.(2015). Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells. Oncotarget, 6(21), 18504-18517. doi: 10.18632/oncotarget.4181. UCLA: Retrieved from: http://www.escholarship.org/uc/item/7xs768kb
Oncotarget, vol 6, iss 21
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer, with 600,000 new cases every year worldwide. Although chemotherapeutics exist, five-year survival is only 50%. New strategies to overcome drug resistance are required to i